The Ras-membrane interface: Isoform-specific differences in the catalytic domain

Molecular Cancer Research

Volumn 13, Issue 4, 2015, Pages 595-603

  Parker, Jillian A ^a   Mattos, Carla ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; PROTEIN BINDING; RAS PROTEIN;

ALLOSTERISM; CATALYSIS; CELL MEMBRANE; CONFORMATIONAL TRANSITION; HUMAN; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; REVIEW; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME ACTIVE SITE; GENETICS; METABOLISM; PROTEIN SECONDARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

CATALYTIC DOMAIN; CELL MEMBRANE; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, SECONDARY; RAS PROTEINS;

EID: 84927615339     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-14-0535     Document Type: Review

References (75)

1. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 1991;349:117-27.
2. Li G, Zhang XC. GTP hydrolysis mechanism of Ras-like GTPases. J Mol Biol 2004;340:921-32.
3. Hancock JF, Parton RG. Ras plasma membrane signalling platforms. Biochem J 2005;389:1-11.
4. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat RevMol Cell Biol 2008;9:517-31.
5. Prior IA, Lewis PD, Mattos C. A comprehensive survey of Ras mutations in cancer. Cancer Res 2012;72:2457-67.
6. Gremer L, Gilsbach B, Ahmadian MR, Wittinghofer A. Fluoride complexes of oncogenic Ras mutants to study the Ras-RasGap interaction. Biol Chem 2008;389:1163-71.
7. Henis YI, Hancock JF, Prior IA. Ras acylation, compartmentalization and signaling nanoclusters. Mol Membr Biol 2009;26:80-92.
8. Prior IA, Hancock JF. Ras trafficking, localization and compartmentalized signalling. Semin Cell Dev Biol 2012;23:145-53.
9. Abankwa D, Gorfe AA, Hancock JF. Mechanisms of Ras membrane organization and signalling: Ras on a rocker. Cell Cycle 2008;7:2667-73.
10. Buhrman G, O'Connor C, Zerbe B, Kearney BM, Napoleon R, Kovrigina EA, et al. Analysis of binding site hot spots on the surface of Ras GTPase. JMol Biol 2011;413:773-89.
11. Cho H, Wu M, Bilgin B, Walton SP, Chan C. Latest developments in experimental and computational approaches to characterize protein-lipid interactions. Proteomics 2012;12:3273-85.
12. Ahearn IM, Haigis K, Bar-Sagi D, Philips MR. Regulating the regulator: post-translational modification of RAS. Nat Rev Mol Cell Biol 2012; 13:39-51.
13. Shalom-Feuerstein R, Plowman SJ, Rotblat B, Ariotti N, Tian T, Hancock JF, et al. K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3. Cancer Res 2008;68:6608-16.
14. Elad-Sfadia G, Haklai R, Balan E, Kloog Y. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity. J Biol Chem 2004;279:34922-30.
15. DerMardirossian C, Bokoch GM.GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol 2005;15:356-63.
16. Bivona TG, Quatela SE, Bodemann BO, Ahearn IM, Soskis MJ, Mor A, et al. PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell 2006;21:481-93.
17. Sablina AA, Chen W, Arroyo JD, Corral L, Hector M, Bulmer SE, et al. The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell 2007; 129:969-82.
18. Zhou Y, Liang H, Rodkey T, Ariotti N, Parton RG, Hancock JF. Signal integration by lipid-mediated spatial cross talk between ras nanoclusters. Mol Cell Biol 2014;34:862-76.
19. Li Z, Gorfe AA. What drives the clustering of membrane-bound Ras? Small GTPases 2012;3:244-7.
20. Brunsveld L, Waldmann H, Huster D. Membrane binding of lipidated Ras peptides and proteins-The structural point of view. Biochim Biophys Acta 2009;1788:273-88.
21. Buhrman G, Holzapfel G, Fetics S, Mattos C. Allosteric modulation of Ras positions Q61 for a direct role in catalysis. Proc Natl Acad Sci USA 2010;107:4931-6.
22. Okeley NM, Gelb MH. A designed probe for acidic phospholipids reveals the unique enriched anionic character of the cytosolic face of the mammalian plasma membrane. J Biol Chem 2004;279:21833-40.
23. van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 2008;9:112-24.
24. EdidinM. The state of lipid rafts: from modelmembranes to cells. Annu Rev Biophys Biomol Struct 2003;32:257-83.
25. Hakobyan D, Heuer A. Key molecular requirements for raft formation in lipid/cholesterol membranes. PLoS ONE 2014;9:e87369.
26. Simons K, Vaz WL. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 2004;33:269-95.
27. Prior IA, Muncke C, Parton RG, Hancock JF. Direct visualization of Ras proteins in spatially distinct cell surface microdomains. J Cell Biol 2003;160:165-70.
28. Rotblat B, Prior IA, Muncke C, Parton RG, Kloog Y, Henis YI, et al. Three separable domains regulate GTP-dependent association of H-ras with the plasma membrane. Mol Cell Biol 2004;24:6799-810.
29. Laude AJ, Prior IA. Palmitoylation and localisation of RAS isoforms are modulated by the hypervariable linker domain. J Cell Sci 2008;121:421-7.
30. Kapoor S, Weise K, Erlkamp M, Triola G, Waldmann H, Winter R. The role of G-domain orientation and nucleotide state on the Ras isoform-specific membrane interaction. Eur Biophys J 2012;41:801-13.
31. Murray D, Arbuziva A, Hangyas-Mihalyne G, Gambhir A, Ben-Tal N, Honig B, et al. Electrostatic properties of membranes containing acidic lipids and absorbed basic peptides: theory and experiment. Biophys J 1999;77: 3176-88.
32. Finkielstein CV, Overduin M, Capelluto DG. Cell migration and signaling specificity is determined by the phosphatidylserine recognition motif of Rac1. J Biol Chem 2006;281:27317-26.
33. Lippoldt J, Handel C, Dietrich U, Kas JA. Dynamic membrane structure induces temporal pattern formation. Biochim Biophys Acta 2014; 1838:2380-90.
34. Weise K, Kapoor S, Denter C, Nikolaus J, Opitz N, Koch S, et al. Membranemediated induction and sorting of K-Ras microdomain signaling platforms. J Am Chem Soc 2011;133:880-7.
35. Gambhir A, Hangyas-Mihalyne G, Zaitseva I, Cafiso D, Wang J, Pentyala S, et al. Electrostatic seuqestration of PIP2 on phospholipid membranes by basic/aromatic regions of proteins. Biophys J 2004;86:2188-207.
36. Heo WD, Inoue T, Park WS, Kim ML, Park BO, Wandless TJ, et al. PI(3,4,5) P3 and PI(4,5)P2 lipids target proteins with polybasic clusters to the plasma membrane. Science 2006;314:1458-61.
37. McLaughlin S, Murray D. Plasma membrane phosphoinositide organization by protein electrostatics. Nature 2005;438:605-11.
38. Plowman SJ, Ariotti N, Goodall A, Parton RG, Hancock JF. Electrostatic interactions positively regulate K-Ras nanocluster formation and function. Mol Cell Biol 2008;28:4377-85.
39. Pike LJ. The challenge of lipid rafts. J Lipid Res 2009;50:S323-8.
40. Choubey A, Kalia RK, Malmstadt N, Nakano A, Vashishta P. Cholesterol translocation in a phospholipid membrane. Biophys J 2013;104: 2429-36.
41. Plowman SJ, Muncke C, Parton RG, Hancock JF. H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proc Natl Acad Sci USA 2005; 102:15500-5.
42. Parton RG, del Pozo MA. Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol 2013;14:98-112.
43. Ariotti N, Fernandez-Rojo MA, Zhou Y, Hill MM, Rodkey TL, Inder KL, et al. Caveolae regulate the nanoscale organization of the plasma membrane to remotely control Ras signaling. J Cell Biol 2014;204:777-92.
44. Abankwa D, Gorfe AA, Hancock JF. Ras nanoclusters: molecular structure and assembly. Semin Cell Dev Biol 2007;18:599-607.
45. Murakoshi H, Iino R, Kobayashi T, Fujiwara T, Ohshima C, Yoshimura A, et al. Single-molecule imaging analysis of Ras activation in living cells. Proc Natl Acad Sci USA 2004;101:7317-22.
46. Rocks O, Peyker A, Kahms M, Verveer PJ, Koerner C, LumbierresM, et al. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 2005;307:1746-52.
47. Fehrenbacher N, Bar-Sagi D, Philips M. Ras/MAPK signaling from endomembranes. Mol Oncol 2009;3:297-307.
48. Lynch SJ, Zavadil J, Pellicer A. In TCR-stimulated T-cells, N-Ras regulates specific genes and signal transduction pathways. PLoS ONE 2013;8: e63193.
49. Wolfman JC, Planchon SM, Liao J, Wolfman A. Structural and functional consequences of c-N-Ras constitutively associated with intact mitochondria. Biochim Biophys Acta 2006;1763:1108-24.
50. Osman C, Voelker DR, Langer T. Making heads or tails of phospholipids in mitochondria. J Cell Biol 2011;192:7-16.
51. Prior IA, Harding A, Yan J, Sluimer J, Parton R,Hancock JF. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat Cell Biol 2001;3:368-75.
52. Abankwa D, Hanzel-Bayer M, Ariotti N, Plowman S, Gorfe A, Parton R, et al. A novel switch region regultes H-Ras membrane orientation and signal output. EMBO J 2008;27:727-35.
53. Kearney BM, Johnson CW, Roberts DM, Swartz P, Mattos C. DRoP: A water analysis program identifies Ras-GTP-specific pathway of communication between membrane-interacting regions and the active site. J Mol Biol 2014;426:611-29.
54. Gorfe A, Hanzel-Bayer M, Abankwa D, Hancock J, McCammon J. Structure and dynamics of the full-length lipid-modified H-Ras protein in a 1,2-Dimyristoylglycero-3-phosphocholine bilayer. J Med Chem 2007;50: 674-84.
55. Prakash P, Gorfe AA. Lessons from computer simulations of Ras proteins in solution and in membrane. Biochim Biophys Acta 2013;1830:5211-8.
56. Guzmán C, S?olman M, Ligabue A, Blaževits? O, Andrade DM, Reymond L, et al. The efficacy of Raf kinase recruitment to the GTPase H-ras depends on H-ras membrane conformer specific nanoclustering. J Biol Chem 2014;289:9519-33.
57. Kapoor S, Triola G, Vetter IR, Erklamp M, Waldmann H, Winter R. Revealing conformational substrates of lipidated N-Ras protein by pressure modulation. Proc Natl Acad Sci U S A 2012;109:460-5.
58. Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H, et al. Ras signalling on the endoplasmic reticulum and the Golgi. Nat Cell Biol 2002;4:343-50.
59. Guldenhaupt J, Rudack T, Bachler P, Mann D, Triola G, Waldmann H, et al. N-Ras forms dimers at POPC membranes. Biophys J 2012; 103:1585-93.
60. Abankwa D, Gorfe AA, Inder K, Hancock JF. Ras membrane orientation and nanodomain localization generate isoform diversity. Proc Natl Acad Sci USA 2010;107:1130-5.
61. Raimondi F, Felline A, Portella G, Orozco M, Fanelli F. Light on the structural communication in Ras GTPases. J Biomol Struct Dyn 2013;31: 142-57.
62. Inouye K, Mizutani S, Koide H, Kaziro Y. Formation of the Ras dimer is essential for Raf-1 activation. J Biol Chem 2000;275:3737-40.
63. Lin WC, Iversen L, Tu HL, Rhodes C, Christensen SM, Iwig JS, et al. H-Ras forms dimers on membrane surfaces via a protein-protein interface. Proc Natl Acad Sci U S A 2014;111:2996-3001.
64. Buhrman G, Kumar VS, Cirit M, Haugh JM, Mattos C. Allosteric modulation of Ras-GTP is linked to signal transduction through RAF kinase. J Biol Chem 2011;286:3323-31.
65. Yan J, Roy S, Apolloni A, Lane A, Hancock JF. Ras isoforms vary in their ability to activate Raf-1 and Phosphoinositide 3-Kinase. J Biol Chem 1998;273:24052-6.
66. Baker TL, Zheng H, Walker J, Coloff JL, Buss JE. Distinct rates of palmitate turnover on membrane-bound cellular and oncogenic H-ras. J Biol Chem 2003;278:19292-300.
67. Stephen AG, Esposito D, Bagni RK, McCormick F. Dragging Ras back in the ring. Cancer Cell 2014;25:272-81.
68. O'Connor C, Kovrigin E. Global conformational dynamics in Ras. Biochemistry 2008;47:10244-6.
69. Araki M, Shima F, Yoshikawa Y, Muraoka S, Ijiri Y, Nagahara Y, et al. Solution structure of the state 1 conformer of GTP-bound H-Ras protein and distinct dynamic properties between the state 1 and state 2 conformers. J Biol Chem 2011;286:39644-53.
70. Wang W, FangG, Rudolph J. Ras inhibition via direct Ras binding-is there a path forward? Bioorg Med Chem Lett 2012;22:5766-76.
71. Takashima A, Faller DV. Targeting the RAS oncogene. Expert Opin Ther Targets 2013;17:507-31.
72. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Franklin RA, Montalto G, et al. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. Oncotarget 2012;3:1068-111.
73. Whyte DB, Kirschmeier P, Hockenberry TN, Nunez-Oliva I, James L, Catino JJ, et al. K-and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J Biol Chem 1997;272:14459-64.
74. Laheru D, Shah P, Rajeshkumar NV, McAllister F, Taylor G, Goldsweig H, et al. Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer. Invest New Drugs 2012;30:2391-9.
75. Grant B, Lukman S, Hocker H, Sayyah J, Heller Brown J, McCammon J, et al. Novel allosteric sites on Ras for lead generation. PLoS ONE 2011;6:e25711.